Envision Healthcare, AmSurg reach merger agreement to form new $10 billion company

A week after news broke that two multibillion dollar healthcare service providers were in talks to merge, the deal is done. Envision Healthcare Holdings Inc. and AmSurg Corp. reached an agreement to create a new company worth more than $10 billion.

As reported in the Wall Street Journal, the deal is expected to be finalized by the end of the year, provided approval from shareholders and regulators.

The new company, which will be called Envision Healthcare Corp., will be led by William Sanger, Envision chairman and CEO, who will become executive chairman. AmSurg CEO Christopher Holden will keep the same position with Envision Healthcare.

AmSurg, headquartered in Nashville, Tenn., provides outsourced physician services to hospitals and others. It also has about 250 facilities performing procedures that don’t require an overnight stay. Envision, based in Greenwood Village, Colo., also provides emergency care, anesthesiology and surgery, and to ambulance and other medical-transportation services.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel. 

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.